Literature DB >> 20409829

Is it the blood pressure or the blood vessel?

Jay N Cohn1.   

Abstract

The physiologic link between vascular health and arterial pressure makes it difficult to separate the adverse effects of pressure and vascular functional and structural alterations in determining the adverse complications of hypertension. Since endothelial dysfunction and nitric oxide deficiency are characteristic features of hypertension and of other risk factors for morbid events, it is proposed that blood pressure elevation may be viewed in part as a complication of functional and structural changes in the microcirculation, and that structural changes in the conduit arteries leading to morbid events may be viewed as a complication of both pressure elevation and endothelial dysfunction. Improvement in endothelial dysfunction will relax the microcirculation and lower blood pressure. Thus pressure elevation and its lowering in resposne to treatment serves as a useful guide to the vascular abnormality and its amelioration, but vascular structural abnormalities are the proximate cause of vascular events and therapy aimed at the vasculature rather than the pressure may serve as a more sensitive and specific guide to treatment.

Entities:  

Year:  2007        PMID: 20409829     DOI: 10.1016/j.jash.2006.11.001

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  9 in total

1.  Heart failure is preventable.

Authors:  Jay N Cohn
Journal:  Curr Heart Fail Rep       Date:  2010-09

2.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

3.  Alterations in capillary morphology are found in mild blood pressure elevation.

Authors:  Cynthia Cheng; Constantine Daskalakis; Bonita Falkner
Journal:  J Hypertens       Date:  2010-11       Impact factor: 4.844

4.  Functional capillary rarefaction in mild blood pressure elevation.

Authors:  Cynthia Cheng; James J Diamond; Bonita Falkner
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

Review 5.  Does it matter how you lower blood pressure in patients with uncomplicated hypertension? Weighing the evidence.

Authors:  Daniel A Duprez
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

6.  Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study.

Authors:  Susan Cheng; Vanessa Xanthakis; Lisa M Sullivan; Ramachandran S Vasan
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

7.  Capillary rarefaction in treated and untreated hypertensive subjects.

Authors:  Cynthia Cheng; Constantine Daskalakis; Bonita Falkner
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-04

8.  Association of capillary density and function measures with blood pressure, fasting plasma glucose, and insulin sensitivity.

Authors:  Cynthia Cheng; Constantine Daskalakis; Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-02-01       Impact factor: 3.738

9.  Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.

Authors:  G D Radchenko; Y M Sirenko; S M Kushnir; O O Torbas; A S Dobrokhod
Journal:  Vasc Health Risk Manag       Date:  2013-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.